Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
Big Business This Week: Who’s Gonna Pick Your Fruit?
The economic cost of deporting immigrants. Plus, Elon had another busy week, inflation is complicated, and endless shrimp meets its end.
NBA Commissioner: ‘We Measure Ourselves Against the Biggest Brands’
NBA Commissioner Adam Silver talks Emirates partnership, stance on social media, and why Amazon is the league's next growth opportunity.
Exclusive: NBA Commissioner Says "We Measure Ourselves Against the Biggest Brands in the World"
NBA Commissioner Adam Silver talks Emirates partnership, stance on social media, and why Amazon is the league's next growth opportunity
Costco Just Recalled 80,000 Pounds of Butter for a Surprising Reason
The retailer announced a voluntary recall of almost 80,000 pounds of butter due to its packaging not having the phrase “Contains Milk.”
The Value Wars Rage on for Fast-Casual Food Chains
Food Chains around the world are racing to add value to their menus options, but why? And how? Bob Wright, CEO of Potbelly joined Cheddar to discuss.
Understanding How Bitcoin Soared To $90,000
Johann Kerbrat, VP and General Manager at Robinhood joins Cheddar to discuss Bitcoin's recent rise and how the company got into election betting. Watch!
Need a Digital Detox Following the Election? Cisco thinks so...
Guy Diedrich, SVP and Global Innovation Officer at Cisco joined Cheddar to discuss how our digital diets impact our well being & an upcoming study to prove it!
BBTW: Are Tariffs a Good Idea? No. But Will They Work? Also No.
This is just what all the economists say about Trump's plan. Plus: Elon had a good week, Boeing's recovering, and Warren Buffett has too much cash.
Markets Skyrocket Post 2024 Election
With the election behind us, many are wondering what the next four years look like for the US economy. Drew Pettit, from Citi Group joins Cheddar to discuss.
